Results 51 to 60 of about 296,180 (402)

High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis [PDF]

, 2014
Aims: High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition from hypertrophy to heart failure in aortic stenosis.
A. L. Hunter, A. Maria Choy, A. S. V. Shah, C. C. Lang, C. W. L. Chin, Cowell, D. A. McAllister, D. E. Newby, Dweck, Dweck, F. E. Strachan, J. P. Langrish, M. R. Dweck, Messroghli, Mills, N. A. Boon, N. L. Mills, Nkomo, Rosjo, S. Alam, S. Joanna Cowell, S. Walker, Thygesen, Wieczorek   +23 more
core   +5 more sources

Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.

European Heart Journal, 2020
AIMS We sought to perform a head-to-head comparison of contemporary 30-day outcomes and readmissions between valve-in-valve transcatheter aortic valve replacement (VIV-TAVR) patients and a matched cohort of high-risk reoperative surgical aortic valve ...
S. Hirji, E. Percy, C. Zogg, Alexandra Malarczyk, M. Harloff, F. Yazdchi, T. Kaneko   +6 more
semanticscholar   +1 more source

Aortic valve replacement with preserved aortic valve homografts

The Journal of Thoracic and Cardiovascular Surgery, 1974
A total of 229 patients underwent aortic valve replacement with a preserved aortic valve homograft during a 7½ year period. The operative mortality rate was 4.8 per cent. Statistical analysis of follow-up data indicated that, for patients who survived the first 30 days after surgery, the 4 year survival rate was 94 per cent and the 7 year survival was ...
R B, Wallace, S P, Londe, J L, Titus
openaire   +2 more sources

Bridging aortic valve surgery to 21st century. what can a surgeon do [PDF]

, 2019
Aortic valve stenosis is the most clinically relevant valvular heart disease in the elderlies. Surgical aortic valve replacement (SAVR) represented, for decades, the standard of care for the treatment of severe aortic stenosis.
Barretta, Antonio, Biondi-Zoccai, Giuseppe, D��Abramo, Mizar, Ferrante, Luisa, Frati, Giacomo, Greco, Ernesto, Guerrera, Manuel, Iaccarino, Alessandra, Marullo, Antonino, Miraldi, Fabio, Peruzzi, Mariangela, Proietti, Piero, Saade, Wael, Sciarretta, Sebastiano   +13 more
core   +1 more source

Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Few randomized trials have compared bioprostheses for transcatheter aortic valve replacement, and no trials have compared bioprostheses with supra-annular design.
C. Tamburino, S. Bleiziffer, H. Thiele, S. Scholtz, D. Hildick-Smith, M. Cunnington, A. Wolf, M. Barbanti, D. Tchétché, P. Garot, P. Pagnotta, M. Gilard, F. Bedogni, E. Van Belle, M. Vasa-Nicotera, A. Chieffo, O. Deutsch, J. Kempfert, L. Søndergaard, C. Butter, Ramiro Trillo-Nouche, S. Lotfi, H. Möllmann, M. Joner, M. Abdel-Wahab, K. Bogaerts, C. Hengstenberg, D. Capodanno   +27 more
semanticscholar   +1 more source

Results of matching valve and root repair to aortic valve and root pathology [PDF]

, 2011
ObjectiveFor patients with aortic root pathology and aortic valve regurgitation, aortic valve replacement is problematic because no durable bioprosthesis exists, and mechanical valves require lifetime anticoagulation. This study sought to assess outcomes
Lars G. Svensson, Lillian H. Batizy, Eugene H. Blackstone, A. Marc Gillinov, Michael C. Moon, Richard S. D’Agostino, Edward M. Nadolny, William J. Stewart, Brian P. Griffin, Donald F. Hammer, Richard Grimm, Bruce W. Lytle, Svensson, Svensson, Miller, Karck, Kallenbach, Akins, Zellner, David, Sarsam, David, Svensson, Schafers, Leyh, van Son, Burkhart, Svensson, David, De Paulis, Pethig, Harringer, Frater, Casselman, El Khoury, Hopkins, Wolfe, Banbury, Rubin, Rosenbaum, Blackstone, Drake, Blackstone, Breiman, Silverman, Svensson, Svensson, Pettersson, Svensson, Svensson, Svensson, Miller   +51 more
core   +2 more sources

Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Patients with bicuspid aortic valve (AV) stenosis were excluded from the pivotal evaluations of transcatheter AV replacement (TAVR) devices.
Sharif A. Halim, Fred H. Edwards, David Dai, Zhuokai Li, Michael J. Mack, David R. Holmes, E. Tuzcu, V. Thourani, J. Harrison, J. M. Brennan   +9 more
semanticscholar   +1 more source

Impact of frailty on outcomes and readmissions after transcatheter and surgical aortic valve replacement in a national cohortCentral MessagePerspective

JTCVS Open
Objective: We examined the effect of frailty on in-hospital mortality, readmission rates, and hospitalization costs after transcatheter and surgical aortic valve replacement in a population-level cohort.
Travis J. Miles, MD, Christopher T. Ryan, MD, Katie J. Hogan, PhD, Bhavesh S. Sayal, BS, Christopher B. Sylvester, MD, PhD, Todd K. Rosengart, MD, Joseph S. Coselli, MD, Marc R. Moon, MD, Ravi K. Ghanta, MD, Subhasis Chatterjee, MD   +9 more
doaj   +1 more source

Determinants of device success after transcatheter aortic valve replacement in patients with type-0 bicuspid aortic stenosis

Frontiers in Cardiovascular Medicine, 2023
BackgroundClinical evidence of transcatheter aortic valve replacement in patients with type-0 bicuspid aortic valve was relatively scarce.AimsOur goal was to explore determinants of device success after transcatheter aortic valve replacement in patients ...
Zhicheng Xiao, Jing Yao, Xinmin Liu, Fei Yuan, Yunfeng Yan, Taiyang Luo, Moyang Wang, Hongliang Zhang, Faxin Ren, Guangyuan Song   +9 more
doaj   +1 more source

Transcatheter Aortic Valve Replacement on an Aortic Mechanical Valve

JACC: Cardiovascular Interventions, 2018
A 71-year-old woman with a history of rheumatic heart valve disease and prior aortic and mitral mechanical valve replacement (Carbomedics #21 and #29, CarboMedics Inc., Austin, Texas, respectively), was referred for transcatheter closure of a mitral perivalvular leak due to New York ...
Dabit, Arzamendi, Valeriano, Ruiz, Raúl, Ramallal, Maria Soledad, Alcasena, Maria Teresa, Beunza, Mariano, Larman   +5 more
openaire   +2 more sources